Buy Biocon, target price Rs 340: Anand Rathi
Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2023.

Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 34769.38 Crore) operating in Pharmaceuticals sector.
Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2023.
Financials
For the quarter ended 31-12-2023, the company reported a Consolidated Total Income of Rs 4519.20 Crore, up 24.83 % from last quarter Total Income of Rs 3620.20 Crore and up 49.66 % from last year same quarter Total Income of Rs 3019.70 Crore. Company reported net profit after tax of Rs 777.40 Crore in latest quarter.
Promoters held 60.64 per cent stake in the company as of 31-Mar-2024, while FIIs owned 5.63 per cent, DIIs 13.68 per cent.
Download ET Markets APP